Dr Rebecca Mercieca-Bebber is an NHMRC Early Career Fellow and the Quality of Life Lead at the NHMRC Clinical Trials Centre, the University of Sydney. Her research focuses on the methodology of patient-reported outcomes (PROs) in clinical trials and she leads the PRO endpoints of several oncology, COVID-19 and nephrology Australian and international clinical trials. She also co-leads the CTC’s consumer involvement initiative, which aims to support researchers and patient partners to engage meaningfully throughout the research process.